<VariationArchive RecordType="classified" VariationID="224873" VariationName="NM_003238.6(TGFB2):c.1022_1026del (p.Tyr341fs)" VariationType="Deletion" Accession="VCV000224873" Version="2" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2022-11-29" DateCreated="2014-04-27" MostRecentSubmission="2016-04-03">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="226715" VariationID="224873">
      <GeneList>
        <Gene Symbol="TGFB2" FullName="transforming growth factor beta 2" GeneID="7042" HGNC_ID="HGNC:11768" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>1q41</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="218345336" stop="218444619" display_start="218345336" display_stop="218444619" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="218518675" stop="218617960" display_start="218518675" display_stop="218617960" Strand="+" />
          </Location>
          <OMIM>190220</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_003238.6(TGFB2):c.1022_1026del (p.Tyr341fs)</Name>
      <CanonicalSPDI>NC_000001.11:218437430:TACAAT:T</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>1q41</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="218437431" stop="218437435" display_start="218437431" display_stop="218437435" variantLength="5" positionVCF="218437430" referenceAlleleVCF="GTACAA" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="218610773" stop="218610777" display_start="218610773" display_stop="218610777" variantLength="5" positionVCF="218610772" referenceAlleleVCF="GTACAA" alternateAlleleVCF="G" />
      </Location>
      <ProteinChange>Y341fs</ProteinChange>
      <ProteinChange>Y369fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.10" sequenceAccession="NC_000001" sequenceVersion="10" change="g.218610774_218610778del" Assembly="GRCh37">
            <Expression>NC_000001.10:g.218610774_218610778del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.11" sequenceAccession="NC_000001" sequenceVersion="11" change="g.218437432_218437436del" Assembly="GRCh38">
            <Expression>NC_000001.11:g.218437432_218437436del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_027721.2" sequenceAccession="NG_027721" sequenceVersion="2" change="g.97099_97103del">
            <Expression>NG_027721.2:g.97099_97103del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001135599.4" sequenceAccession="NM_001135599" sequenceVersion="4" change="c.1106_1110del">
            <Expression>NM_001135599.4:c.1106_1110del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001129071.1" sequenceAccession="NP_001129071" sequenceVersion="1" change="p.Tyr369fs">
            <Expression>NP_001129071.1:p.Tyr369fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_003238.6" sequenceAccession="NM_003238" sequenceVersion="6" change="c.1022_1026del" MANESelect="true">
            <Expression>NM_003238.6:c.1022_1026del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_003229.1" sequenceAccession="NP_003229" sequenceVersion="1" change="p.Tyr341fs">
            <Expression>NP_003229.1:p.Tyr341fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_138148.2" sequenceAccession="NR_138148" sequenceVersion="2" change="n.2273_2277del">
            <Expression>NR_138148.2:n.2273_2277del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_138149.2" sequenceAccession="NR_138149" sequenceVersion="2" change="n.2357_2361del">
            <Expression>NR_138149.2:n.2357_2361del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA281903" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="190220.0003" DB="OMIM" />
        <XRef Type="rs" ID="398122884" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_003238.6(TGFB2):c.1022_1026del (p.Tyr341fs) AND Loeys-Dietz syndrome 4" Accession="RCV000210478" Version="4">
        <ClassifiedConditionList TraitSetID="8852">
          <ClassifiedCondition DB="MedGen" ID="C3553762">Loeys-Dietz syndrome 4</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2014-04-27" MostRecentSubmission="2016-04-03">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">22772368</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22772371</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="8852" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17363" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Loeys-Dietz syndrome 4</ElementValue>
                <XRef ID="MONDO:0013897" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">ANEURYSM, AORTIC AND CEREBRAL, WITH ARTERIAL TORTUOSITY AND SKELETAL MANIFESTATIONS</ElementValue>
                <XRef Type="MIM" ID="614816" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">LDS4</ElementValue>
                <XRef Type="MIM" ID="614816" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Loeys-Dietz syndrome (LDS) is characterized by vascular findings (cerebral, thoracic, and abdominal arterial aneurysms and/or dissections), skeletal manifestations (pectus excavatum or pectus carinatum, scoliosis, joint laxity, arachnodactyly, talipes equinovarus, cervical spine malformation and/or instability), craniofacial features (widely spaced eyes, strabismus, bifid uvula / cleft palate, and craniosynostosis that can involve any sutures), and cutaneous findings (velvety and translucent skin, easy bruising, and dystrophic scars). Individuals with LDS are predisposed to widespread and aggressive arterial aneurysms and pregnancy-related complications including uterine rupture and death. Individuals with LDS can show a strong predisposition for allergic/inflammatory disease including asthma, eczema, and reactions to food or environmental allergens. There is also an increased incidence of gastrointestinal inflammation including eosinophilic esophagitis and gastritis or inflammatory bowel disease. Wide variation in the distribution and severity of clinical features can be seen in individuals with LDS, even among affected individuals within a family who have the same pathogenic variant.</Attribute>
                <XRef ID="NBK1133" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10588" />
                <XRef ID="10588" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301312</ID>
                <ID Source="BookShelf">NBK1133</ID>
              </Citation>
              <XRef ID="C3553762" DB="MedGen" />
              <XRef ID="MONDO:0013897" DB="MONDO" />
              <XRef Type="MIM" ID="614816" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="88497" SubmissionDate="2014-04-22" DateLastUpdated="2014-04-27" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="190220.0003_LOEYS-DIETZ SYNDROME 4" title="TGFB2, 5-BP DEL, 1021TACAA_LOEYS-DIETZ SYNDROME 4" />
        <ClinVarAccession Accession="SCV000053395" DateUpdated="2014-04-27" DateCreated="2013-04-04" Type="SCV" Version="3" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2012-07-08">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In affected members of a large 4-generation US family with syndromic thoracic aortic aneurysm (LDS4; 614816), Boileau et al. (2012) identified heterozygosity for a 5-bp deletion (1021_1025delTACAA) in exon 6 of the TGFB2 gene, causing a frameshift resulting in a premature termination codon. TGFB2 expression was similar in smooth muscle cells and dermal fibroblasts from a patient and control cells, but immunoblot analysis of the TGF-beta-2 proprotein in cellular lysates from these cells showed lower amounts of TGF-beta-2 proprotein in mutant cells compared to wildtype with no evidence of a truncated protein, suggesting rapid degradation of the expressed mutant protein.</Attribute>
              <Citation>
                <ID Source="PubMed">22772371</ID>
              </Citation>
              <XRef DB="OMIM" ID="614816" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TGFB2" />
          </GeneList>
          <Name>TGFB2, 5-BP DEL, 1021TACAA</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">5-BP DEL, 1021TACAA</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="190220.0003" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">LOEYS-DIETZ SYNDROME 4</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="499329" SubmissionDate="2015-09-15" DateLastUpdated="2016-04-03" DateCreated="2016-04-03">
        <ClinVarSubmissionID localKey="NM_001135599.2:c.1106_1110delACAAT|OMIM:614816" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000266541" DateUpdated="2016-04-03" DateCreated="2016-04-03" Type="SCV" Version="1" SubmitterName="Baylor-Hopkins Center for Mendelian Genomics, Johns Hopkins University School of Medicine" OrgID="505755" OrganizationCategory="laboratory" OrgAbbreviation="BHCMG-JH" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Submitter's publication</Attribute>
          <Citation>
            <ID Source="PubMed">22772368</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <FamilyData NumFamiliesWithVariant="1" />
            </Sample>
            <Method>
              <MethodType>research</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="1" />
            </ObservedData>
            <Citation>
              <ID Source="PubMed">22772368</ID>
            </Citation>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TGFB2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001135599.2:c.1106_1110delACAAT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="614816" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>BHCMG_ClinVar_2015Sept</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="88497" TraitType="Disease" MappingType="Name" MappingValue="LOEYS-DIETZ SYNDROME 4" MappingRef="Preferred">
        <MedGen CUI="C3553762" Name="Loeys-Dietz syndrome 4" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="499329" TraitType="Disease" MappingType="XRef" MappingValue="614816" MappingRef="OMIM">
        <MedGen CUI="C3553762" Name="Loeys-Dietz syndrome 4" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

